Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis
- PMID: 17556654
- DOI: 10.1161/ATVBAHA.107.141911
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis
Abstract
Hemostasis requires both platelets and the coagulation system. At sites of vessel injury, bleeding is minimized by the formation of a hemostatic plug consisting of platelets and fibrin. The traditional view of the regulation of blood coagulation is that the initiation phase is triggered by the extrinsic pathway, whereas amplification requires the intrinsic pathway. The extrinsic pathway consists of the transmembrane receptor tissue factor (TF) and plasma factor VII/VIIa (FVII/FVIIa), and the intrinsic pathway consists of plasma FXI, FIX, and FVIII. Under physiological conditions, TF is constitutively expressed by adventitial cells surrounding blood vessels and initiates clotting. In addition so-called blood-borne TF in the form of cell-derived microparticles (MPs) and TF expression within platelets suggests that TF may play a role in the amplification phase of the coagulation cascade. Under pathologic conditions, TF is expressed by monocytes, neutrophils, endothelial cells, and platelets, which results in an elevation of the levels of circulating TF-positive MPs. TF expression within the vasculature likely contributes to thrombosis in a variety of diseases. Understanding how the extrinsic pathway of blood coagulation contributes to hemostasis and thrombosis may lead to the development of safe and effective hemostatic agents and antithrombotic drugs.
Similar articles
-
Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.Platelets. 2008 Feb;19(1):9-23. doi: 10.1080/09537100701817232. Platelets. 2008. PMID: 18231934 Review.
-
Role of tissue factor in hemostasis and thrombosis.Blood Cells Mol Dis. 2006 Mar-Apr;36(2):104-7. doi: 10.1016/j.bcmd.2005.12.008. Epub 2006 Feb 7. Blood Cells Mol Dis. 2006. PMID: 16466951 Review.
-
[Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].Ital Heart J Suppl. 2003 Jul;4(7):559-68. Ital Heart J Suppl. 2003. PMID: 14558284 Review. Italian.
-
Role of tissue factor in hemostasis, thrombosis, and vascular development.Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1015-22. doi: 10.1161/01.ATV.0000130465.23430.74. Epub 2004 Apr 29. Arterioscler Thromb Vasc Biol. 2004. PMID: 15117736 Review.
-
[The role of tissue factor and its inhibitor in hemostasis].Przegl Lek. 1998;55(2):68-73. Przegl Lek. 1998. PMID: 9695646 Review. Polish.
Cited by
-
Characterization of the Biodistribution and Systemic Absorption of TT-173, a New Hemostatic Agent of Recombinant Human Tissue Factor, Using Radiolabeling with 18F.Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):583-592. doi: 10.1007/s13318-016-0366-x. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27550654
-
Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians.Mol Biol Rep. 2013 May;40(5):3793-8. doi: 10.1007/s11033-012-2456-4. Epub 2012 Dec 30. Mol Biol Rep. 2013. PMID: 23275237
-
Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.Res Pract Thromb Haemost. 2022 Oct 13;6(7):e12815. doi: 10.1002/rth2.12815. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36254255 Free PMC article.
-
Integrating platelet and coagulation activation in fibrin clot formation.Res Pract Thromb Haemost. 2018 May 20;2(3):450-460. doi: 10.1002/rth2.12107. eCollection 2018 Jul. Res Pract Thromb Haemost. 2018. PMID: 30046749 Free PMC article. Review.
-
HIV-Associated Venous Thromboembolism.Mediterr J Hematol Infect Dis. 2011;3(1):e2011030. doi: 10.4084/MJHID.2011.030. Epub 2011 Jul 8. Mediterr J Hematol Infect Dis. 2011. PMID: 21869916 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous